Company Filing History:
2 out of 48 
1 out of 5,089 
1 out of 68 Years Active: 2022-2025
Title: Jean-Claude Brouet: Innovator in Chimeric Protein Research
Introduction
Jean-Claude Brouet is a notable inventor based in Paris, France. He has made significant contributions to the field of biomedical research, particularly in the development of chimeric proteins for therapeutic applications. With a total of 2 patents, his work has the potential to impact the treatment of amyloidosis.
Latest Patents
Brouet's latest patents focus on a chimeric protein designed for the treatment of amyloidosis. The first patent describes a chimeric protein that comprises at least one human amyloid P component and at least one fragment of an Fc region of a human antibody. These components are bound together by a hinge region, which is crucial for their functionality. This innovative approach aims to enhance the therapeutic efficacy of treatments for amyloidosis.
Career Highlights
Throughout his career, Jean-Claude Brouet has worked with prestigious institutions such as Université De Limoges and the Centre National De La Recherche Scientifique. His research has been instrumental in advancing the understanding of amyloidosis and developing new treatment strategies.
Collaborations
Brouet has collaborated with notable colleagues, including Christophe De Romeuf and Christophe Sirac. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Jean-Claude Brouet's contributions to the field of chimeric proteins and his ongoing research in amyloidosis highlight his role as a significant inventor in biomedical science. His work continues to pave the way for new therapeutic options in the treatment of complex diseases.